TerminatedPhase 4ACTRN12605000175673
INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTAN
Sponsor
University of Western Australia
Enrollment
40 participants
Start Date
May 1, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTAN. Participation likely involves blood tests.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Atorvastatin 80mg or Irbesartan 150mg for 21 days
Atorvastatin 80mg or Irbesartan 150mg for 21 days
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000175673
Related Trials
efficacy of LOw dose antihypertensive and lipid lowering pill combinations To improve stroke oUtcomeS (LOTUS)
ACTRN1262400127951614 locations
Stroke in patients with Very large Ischaemic Core: Assessment of Reperfusion therapy Impact on Outcome (SICARIO-VLC)
ACTRN1262200088074114 locations
Effect of different Lifestyle Interventions on Vascular Risk factors and Arterial stiffness in Non-disabling Stroke and Transient Ischemic Attack (TIA) patients
ACTRN126150005195501 location